Biofilm surface area in the pediatric nasopharynx: Chronic rhinosinusitis vs obstructive sleep apnea
- PMID: 17309976
- DOI: 10.1001/archotol.133.2.110
Biofilm surface area in the pediatric nasopharynx: Chronic rhinosinusitis vs obstructive sleep apnea
Abstract
Objective: To compare the percentage of mucosal surface area of adenoids infected with biofilms removed from children with chronic rhinosinusitis (CRS) vs children with obstructive sleep apnea (OSA).
Design: Comparative microanatomical investigation of adenoid mucosa from patients with CRS and OSA using scanning electron microscopy.
Setting: University-affiliated hospitals and ambulatory surgery center.
Patients: Four girls and 12 boys ranging in age from 3 months to 10 years.
Main outcome measure: Measurements of biofilm coverage of the entire adenoidal surface.
Results: Adenoids removed from patients with CRS had dense mature biofilms covering the mucosal surface; they had a mean of 94.9% of their mucosal surface covered with mature biofilms, compared with a mean of 1.9% coverage on the adenoids removed from patients with OSA. This difference was statistically significant at P < .001.
Conclusions: Adenoids removed from patients with CRS had almost their entire mucosal surface covered with biofilms vs scant coverage for patients with OSA. Biofilms in the nasopharynx of children with CRS may act as a chronic reservoir for bacterial pathogens resistant to standard antibiotics. The mechanical debridement of the nasopharyngeal biofilms may explain the observed clinical benefit associated with adenoidectomy in this subset of pediatric patients.
Comment in
-
Notice of duplicate publication: "Biofilm Surface Area in the Pediatric Nasopharynx: Chronic Rhinosinusitis vs Obstructive Sleep Apnea" (Arch Otolaryngol Head Neck Surg. 2007;133[2]:110-114).Arch Otolaryngol Head Neck Surg. 2007 Aug;133(8):843; author reply 843. doi: 10.1001/archotol.133.8.843-a. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17709631 No abstract available.
Similar articles
-
Identification of adenoid biofilms in chronic rhinosinusitis.Int J Pediatr Otorhinolaryngol. 2006 Sep;70(9):1613-7. doi: 10.1016/j.ijporl.2006.05.002. Epub 2006 Jun 16. Int J Pediatr Otorhinolaryngol. 2006. PMID: 16781783
-
Biofilms and chronic otitis media: an initial exploration into the role of biofilms in the pathogenesis of chronic otitis media.Am J Otolaryngol. 2010 Jul-Aug;31(4):241-5. doi: 10.1016/j.amjoto.2009.02.015. Epub 2009 Jun 3. Am J Otolaryngol. 2010. PMID: 20015753
-
Biofilm density in the pediatric nasopharynx: recurrent acute otitis media versus obstructive sleep apnea.Ann Otol Rhinol Laryngol. 2009 Jul;118(7):519-24. doi: 10.1177/000348940911800711. Ann Otol Rhinol Laryngol. 2009. PMID: 19708492
-
Chronic rhinosinusitis and bacterial biofilms.Curr Opin Otolaryngol Head Neck Surg. 2006 Jun;14(3):183-6. doi: 10.1097/01.moo.0000193177.62074.fd. Curr Opin Otolaryngol Head Neck Surg. 2006. PMID: 16728897 Review.
-
Rhinosinusitis and otitis media: the link with adenoids.Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1 Suppl):38-40. Int J Immunopathol Pharmacol. 2010. PMID: 20152078 Review.
Cited by
-
[Expert consensus on the diagnosis and treatment of chronic sinusitis in children].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Dec;38(12):1091-1099. doi: 10.13201/j.issn.2096-7993.2024.12.001. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024. PMID: 39605255 Free PMC article. Chinese.
-
Rhinosinusitis in children.ISRN Otolaryngol. 2012 Dec 5;2012:851831. doi: 10.5402/2012/851831. Print 2012. ISRN Otolaryngol. 2012. PMID: 23762621 Free PMC article.
-
Ribosomal therapy in the treatment of recurrent acute adenoiditis.Eur Arch Otorhinolaryngol. 2010 Aug;267(8):1313-8. doi: 10.1007/s00405-009-1193-3. Epub 2010 Jan 6. Eur Arch Otorhinolaryngol. 2010. PMID: 20052587 Clinical Trial.
-
Chronic Rhinosinusitis in Children: Pathophysiology, Evaluation, and Medical Management.Curr Allergy Asthma Rep. 2018 May 29;18(7):37. doi: 10.1007/s11882-018-0792-8. Curr Allergy Asthma Rep. 2018. PMID: 29845321 Review.
-
Modulation of hyaluronan signaling as a therapeutic target in human disease.Pharmacol Ther. 2022 Apr;232:107993. doi: 10.1016/j.pharmthera.2021.107993. Epub 2021 Sep 26. Pharmacol Ther. 2022. PMID: 34587477 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical